SCHEMBL10112017

SCHEMBL10112017

Fc1ccc(Cl)c(N2CC3(CCNCC3)C2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.45
SLC6A2 P23975 3/20 0.42
SLC6A4 P31645 3/20 0.42
SLC6A3 Q01959 3/20 0.42
HTR1A P08908 1/20 0.42
ADRA1A P35348 1/20 0.42
ADRA1B P35368 1/20 0.42
CYP2D6 P10635 6/20 0.41
ALDH1A1 P00352 5/20 0.41
USP2 O75604 5/20 0.41
HSD17B10 Q99714 4/20 0.41
CYP1A2 P05177 4/20 0.41
TP53 P04637 2/20 0.41
MAPK1 P28482 2/20 0.41
HIF1A Q16665 1/20 0.41
ALOX15 P16050 1/20 0.41
HPGD P15428 3/20 0.41
CYP3A4 P08684 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
SOS1 Q07889 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL1394557 0.89 USP2 (0.42) TSHRSLC6A2SLC6A4SLC6A3HTR1A
SCHEMBL10112057 0.84 HTR1A (0.41) SLC6A2SLC6A4SLC6A3HTR1AADRA1A
SCHEMBL6927948 0.81 TSHR (0.47) TSHRSLC6A2SLC6A4SLC6A3HTR1A
SCHEMBL6195922 0.79 ADRB1 (0.59) SLC6A2SLC6A4SLC6A3HTR1AALDH1A1
Hydrochloric Acid SCHEMBL3710005 0.78 ADRB1 (0.58) SLC6A2SLC6A4SLC6A3HTR1ACYP2D6
SCHEMBL1395113 0.76 CYP3A4 (0.47) TSHRHTR1AADRA1AADRA1BCYP2D6
SCHEMBL10112002 0.76 HTR1A (0.47) SLC6A2SLC6A4SLC6A3HTR1AADRA1A
Trifluoroacetic Acid SCHEMBL1394390 0.74 SCD (0.42) HTR1AADRA1AADRA1BSCD
SCHEMBL13261278 0.74 ADRB1 (0.53) SLC6A2SLC6A4SLC6A3HTR1AADRA1A
SCHEMBL1394565 0.74 SCD (0.48) HTR1AADRA1AADRA1BCYP2D6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120010186-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2012-01-12 US disclosed
US-20120010186-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2012-01-12 US disclosed
WO-2010108268-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010186-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE SCD, SCD5, FASN TSHR 3261/4885SLC6A2 4701/4885SLC6A4 4659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.